Sheets Smith Wealth Management trimmed its position in UnitedHealth Group Inc (NYSE:UNH) by 8.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,354 shares of the healthcare conglomerate’s stock after selling 649 shares during the quarter. Sheets Smith Wealth Management’s holdings in UnitedHealth Group were worth $1,621,000 at the end of the most recent reporting period.
Other large investors also recently made changes to their positions in the company. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group in the second quarter valued at $110,000. Bruderman Asset Management LLC bought a new stake in UnitedHealth Group in the second quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its position in UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 520 shares during the period. BDO Wealth Advisors LLC bought a new stake in UnitedHealth Group in the second quarter valued at $121,000. Finally, Acrospire Investment Management LLC grew its position in UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after acquiring an additional 400 shares during the period. Hedge funds and other institutional investors own 86.00% of the company’s stock.
UnitedHealth Group Inc (UNH) opened at $229.37 on Friday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.70 and a current ratio of 0.73. UnitedHealth Group Inc has a one year low of $156.49 and a one year high of $250.79. The stock has a market capitalization of $222,270.00, a price-to-earnings ratio of 24.14, a PEG ratio of 1.33 and a beta of 0.70.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.31%. The ex-dividend date of this dividend is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.58%.
In other news, Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction on Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the transaction, the director now owns 1,790,567 shares of the company’s stock, valued at $434,302,025.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares in the company, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. Insiders have sold 53,396 shares of company stock worth $12,262,067 in the last ninety days. 0.89% of the stock is currently owned by insiders.
UNH has been the topic of a number of analyst reports. Cantor Fitzgerald reiterated a “buy” rating and issued a $225.00 price target on shares of UnitedHealth Group in a research report on Monday, November 27th. Jefferies Group reiterated a “buy” rating and issued a $248.00 price target on shares of UnitedHealth Group in a research report on Friday, December 1st. Deutsche Bank upped their price target on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Credit Suisse Group initiated coverage on UnitedHealth Group in a research report on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 price target on the stock. Finally, Royal Bank of Canada upped their price target on UnitedHealth Group to $244.00 and gave the company an “outperform” rating in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Two investment analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $243.22.
COPYRIGHT VIOLATION WARNING: This story was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://stocknewstimes.com/2018/02/17/sheets-smith-wealth-management-sells-649-shares-of-unitedhealth-group-inc-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.